{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T23:10:26Z","timestamp":1774566626950,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1998,3,1]],"date-time":"1998-03-01T00:00:00Z","timestamp":888710400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[1998,3]]},"DOI":"10.1038\/nm0398-328","type":"journal-article","created":{"date-parts":[[2004,8,19]],"date-time":"2004-08-19T01:57:35Z","timestamp":1092880655000},"page":"328-332","source":"Crossref","is-referenced-by-count":2126,"title":["Vaccination of melanoma patients with peptide- or tumorlysate-pulsed dendritic cells"],"prefix":"10.1038","volume":"4","author":[{"given":"Frank O.","family":"Nestle","sequence":"first","affiliation":[]},{"given":"Selma","family":"Alijagic","sequence":"additional","affiliation":[]},{"given":"Michel","family":"Gilliet","sequence":"additional","affiliation":[]},{"given":"Yuansheng","family":"Sun","sequence":"additional","affiliation":[]},{"given":"Stephan","family":"Grabbe","sequence":"additional","affiliation":[]},{"given":"Reinhard","family":"Dummer","sequence":"additional","affiliation":[]},{"given":"G\u00fcnter","family":"Burg","sequence":"additional","affiliation":[]},{"given":"Dirk","family":"Schadendorf","sequence":"additional","affiliation":[]}],"member":"297","reference":[{"key":"BFnm0398328_CR1","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1093\/oxfordjournals.bmb.a072980","volume":"51","author":"RM MacKie","year":"1995","unstructured":"MacKie, R.M. Melanoma prevention and early detection. Br. Med. Bull. 51 570\u2013583 (1995).","journal-title":"Br. Med. Bull."},{"key":"BFnm0398328_CR2","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S0167-5699(97)84664-6","volume":"18","author":"SA Rosenberg","year":"1997","unstructured":"Rosenberg, S.A. Cancer vaccines based on the identification of genes encoding cancer regression antigens. Immunol. Today 18, 175\u2013182 (1997).","journal-title":"Immunol. Today"},{"issue":"1","key":"BFnm0398328_CR3","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1146\/annurev.iy.09.040191.001415","volume":"9","author":"Ralph M. Steinman","year":"1991","unstructured":"Steinman, R.M. The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 9, 271\u2013296(1991).","journal-title":"Annual Review of Immunology"},{"key":"BFnm0398328_CR4","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1002\/eji.1830240317","volume":"24","author":"V Flamand","year":"1994","unstructured":"Flamand, V. et al. Murine dendritic cells pulsed in vitro with tumor antigen induce tumor resistance in vivo. Eur. J. Immunol. 24, 605\u2013610 (1994).","journal-title":"Eur. J. Immunol."},{"issue":"12","key":"BFnm0398328_CR5","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1038\/nm1295-1297","volume":"1","author":"J.I. Mayordomo","year":"1995","unstructured":"Mayordomo, J.I. et al. Bone marrow-derived dendritic cells pulsed with synthetic tumor peptides elicit protective and therapeutic antitumor immunity. Nature Med. 1, 1297\u20131302(1995).","journal-title":"Nature Medicine"},{"key":"BFnm0398328_CR6","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1084\/jem.183.4.1357","volume":"183","author":"JI Mayordomo","year":"1996","unstructured":"Mayordomo, J.I. et al. Therapy of murine tumors with p53 wild-type and mutant sequence peptide-based vaccines. J. Exp. Med. 183, 1357\u20131365 (1996).","journal-title":"J. Exp. Med."},{"key":"BFnm0398328_CR7","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1084\/jem.183.1.317","volume":"183","author":"P Paglia","year":"1996","unstructured":"Paglia, P. et al. Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo. J. Exp. Med. 183, 317\u2013322 (1996).","journal-title":"J. Exp. Med."},{"key":"BFnm0398328_CR8","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.4049\/jimmunol.156.8.2918","volume":"156","author":"A Porgador","year":"1996","unstructured":"Porgador, A. et al. Induction of antitumor immunity using bone marrow-generated dendritic cells. J. Immunol. 156, 2918\u20132926 (1996).","journal-title":"J. Immunol."},{"key":"BFnm0398328_CR9","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.4049\/jimmunol.142.3.1053","volume":"142","author":"J Shimizu","year":"1989","unstructured":"Shimizu, J. et al. Induction of tumor-specific in vivo protective immunity by immunization with tumor antigen-pulsed antigen-presenting cells. J. Immunol. 142, 1053\u20131059 (1989).","journal-title":"J. Immunol."},{"key":"BFnm0398328_CR10","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1084\/jem.183.1.87","volume":"183","author":"L Zitvogel","year":"1996","unstructured":"Zitvogel, L. et al. Therapy of murine tumors with tumor peptide-pulsed dendritic cells: Dependence on T cells, B7 costimulation, and T helper cell 1 -associated cytokines. Exp. Med. 183, 87\u201397 (1996).","journal-title":"Exp. Med."},{"key":"BFnm0398328_CR11","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1084\/jem.183.1.283","volume":"183","author":"C Celluzzi","year":"1996","unstructured":"Celluzzi, C. et al. Peptide-pulsed dendritic cells induce antigen-specific, CTL-mediated protective tumor immunity. J. Exp. Med. 183, 283\u2013287 (1996).","journal-title":"J. Exp. Med."},{"key":"BFnm0398328_CR12","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1002\/ijc.2910630622","volume":"63","author":"M Marchand","year":"1995","unstructured":"Marchand, M. et al. Tumor regression responses in melanoma patients with a peptide encoded by gene MAGE-3. Int. J. Cancer 63, 883\u2013885 (1995).","journal-title":"Int. J. Cancer"},{"key":"BFnm0398328_CR13","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1002\/(SICI)1097-0215(19960410)66:2<162::AID-IJC4>3.0.CO;2-0","volume":"66","author":"E J\u00e4ger","year":"1996","unstructured":"J\u00e4ger, E. et al. Generation of cytotoxic T-cell responses with synthetic melanoma-associated peptides in vivo: Implications for tumor vaccines with melanoma-associated antigens. Int. J. Cancer 66, 162\u2013169 (1996).","journal-title":"Int. J. Cancer"},{"key":"BFnm0398328_CR14","first-page":"37","volume":"3","author":"JN Cormier","year":"1997","unstructured":"Cormier, J.N. et al. Enhancement of cellular immunity in melanoma patient immunized with a peptide from MART-1\/Melan-A. Cancer J. Sci. Am. 3, 37\u201344 (1997).","journal-title":"Cancer J. Sci. Am."},{"issue":"3","key":"BFnm0398328_CR15","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/0167-5699(95)80125-1","volume":"16","author":"Stephan Grabbe","year":"1995","unstructured":"Grabbe, S. et al. Dendritic cells as initiators of tumor immune responses\u2014a possible strategy for tumor immunotherapy? Immunol. Today 16, 117\u2013121 (1995).","journal-title":"Immunology Today"},{"key":"BFnm0398328_CR16","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1126\/science.8493532","volume":"260","author":"A Lanzavecchia","year":"1993","unstructured":"Lanzavecchia, A. Identifying strategies for immune intervention. Science 260, 937\u2013944 (1993).","journal-title":"Science"},{"key":"BFnm0398328_CR17","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/0167-5699(96)80544-5","volume":"17","author":"JH Peters","year":"1996","unstructured":"Peters, J.H. et al. Dendritic cells: from ontogenetic orphans to myelomonocytic descendants. Immunol. Today 17, 273\u2013278 (1996).","journal-title":"Immunol. Today"},{"key":"BFnm0398328_CR18","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/360258a0","volume":"360","author":"C Caux","year":"1992","unstructured":"Caux, C. er al. GM-CSF and TNF-\u03b1 cooperate in the generation of dendritic Langerhans cells. Nature 360, 258\u2013261 (1992).","journal-title":"Nature"},{"key":"BFnm0398328_CR19","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1084\/jem.180.1.83","volume":"180","author":"N Romani","year":"1994","unstructured":"Romani, N. et al. Proliferating dendritic cell progenitors in human blood. J. Exp. Med. 180, 83\u201393 (1994).","journal-title":"J. Exp. Med."},{"key":"BFnm0398328_CR20","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1084\/jem.179.4.1109","volume":"179","author":"F Sallusto","year":"1994","unstructured":"Sallusto, F. & Lanzavecchia, A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte\/macrophage colony-stimulating factor plus interleukin-4 and downregulated by tumor necrosis factor-alpha. J. Exp. Med 179, 1109\u2013111 (1994).","journal-title":"J. Exp. Med"},{"key":"BFnm0398328_CR21","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1084\/jem.186.1.65","volume":"186","author":"SRM Bennett","year":"1997","unstructured":"Bennett, S.R.M. et al. Induction of a CD8+ cytotoxic T lymphocyte response by cross-priming requires cognate CD4+ help. J. Exp. Med. 186, 65\u201370 (1997).","journal-title":"J. Exp. Med."},{"key":"BFnm0398328_CR22","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1146\/annurev.immunol.14.1.333","volume":"14","author":"RM Zinkernagel","year":"1996","unstructured":"Zinkernagel, R.M. et al. On immunological memory. Annu. Rev. Immunol. 14, 333\u2013367. (1996).","journal-title":"Annu. Rev. Immunol."},{"key":"BFnm0398328_CR23","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/nm0196-52","volume":"2","author":"FJ Hsu","year":"1996","unstructured":"Hsu, F.J. et al. Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. Nature Med. 2, 52\u201358 (1996).","journal-title":"Nature Med."},{"key":"BFnm0398328_CR24","doi-asserted-by":"publisher","first-page":"8078","DOI":"10.1073\/pnas.92.17.8078","volume":"92","author":"B Mukherji","year":"1995","unstructured":"Mukherji, B. et al. Induction of antigen-specific cytolytic T cells in situ in human melanoma by immunization with synthetic peptide-pulsed autologous antigen presenting cells. Proc. Natl. Acad Sci. USA 92, 8078\u2013802 (1995).","journal-title":"Proc. Natl. Acad Sci. USA"},{"key":"BFnm0398328_CR25","doi-asserted-by":"publisher","first-page":"3100","DOI":"10.1002\/eji.1830251117","volume":"25","author":"S Alijagic","year":"1995","unstructured":"Alijagic, S. et al. Dendritic cells generated from peripheral blood transfected with human tyrosinase induce specific T cell activation. Eur. J. Immunol. 25, 3100\u20133107 (1995).","journal-title":"Eur. J. Immunol."}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nm0398-328","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm0398-328.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm0398-328.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,14]],"date-time":"2024-01-14T06:15:06Z","timestamp":1705212906000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nm0398-328"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,3]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1998,3]]}},"alternative-id":["BFnm0398328"],"URL":"https:\/\/doi.org\/10.1038\/nm0398-328","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,3]]}}}